Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Rating) and Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation. Volatility and Risk Crinetics Pharmaceuticals has a beta of 0.94, […]
Eli Lilly is selling to Amphastar Pharmaceuticals global rights to Baqsimi, an emergency treatment for severe hypoglycemia in diabetes patients. The deal come as Lilly turns its focus to novel medicines for diabetes and other indications.